Clinical Trials in Dallas

Showing 8921-8940 of 17,468 trials

A Multiple Dose, Dose Escalation Trial of AEB1102 in Patients With Advanced Solid Tumors

NCT02561234

This is the first-in-human study of the safety of increasing dose levels of AEB1102 in patients with advanced cancers. The study will also evaluate the amounts of AEB1102 in blood, the effects of AEB1102 on blood amino acid levels and tumor growth.

Advanced Cancers

Aeglea Biotherapeutics98 participantsStarted Oct 2015

Phoenix, Arizona, United States • Los Angeles, California, United States • Aurora, Colorado, United States +8 more locations

COMPLETEDPhase 3< 1 mile

Study of ProMetic BioTherapeutics Immune Globulin Intravenous (Human) 10%

NCT02269163

Phase 3 multicenter, open-label study of safety, tolerability, efficacy, and pharmacokinetics (PK) of ProMetic's Immune Globulin Intravenous (Human) 10%, the investigational medicinal product \[IMP\]), in Adults and Children with Primary Immunodeficiency Diseases (PIDD).

Primary Immunodeficiency

Prometic Biotherapeutics, Inc.82 participantsStarted Jan 2016

Irvine, California, United States • Los Angeles, California, United States • Centennial, Colorado, United States +10 more locations

A Multiple Dose, Dose Escalation Trial of AEB1102 in Patients With Advanced Solid Tumors

Study of ProMetic BioTherapeutics Immune Globulin Intravenous (Human) 10%

Find Trials by Condition in Dallas

Atazanavir Used in Combination With Other Anti-HIV Drugs in HIV-Infected Infants, Children, and Adolescents

Registrational Study With Omecamtiv Mecarbil (AMG 423) to Treat Chronic Heart Failure With Reduced Ejection Fraction

Psoriatic Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to NSAIDs or Non-biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) Therapy

Study of Topical SOR007 Ointment for Cutaneous Metastases

Evaluating the Safety, Tolerability, and Effect of a Human Monoclonal Antibody (VRC01) on Markers of HIV Persistence in HIV-Infected Adults Receiving Antiretroviral Therapy (ART)

Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women

Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children

DOSE Trial of Opioid Sparing Effect

SI-613 Study for Knee Osteoarthritis

Safety and Immune Response to Vicriviroc in Combination Regimens in HIV-Infected ART Experienced Children and Adolescents

A Randomized, Comparative, Prospective Study of Daily Trimethoprim / Sulfamethoxazole (TMS) and Thrice-Weekly TMS for Prophylaxis Against PCP in HIV-Infected Patients

Study Assessing the Feasibility of a Surgery and Chemotherapy-Only in Children With Wnt Positive Medulloblastoma

A Phase I Concentration-Targeted Multidose Study of Atevirdine Mesylate ( U-87201E ), AZT, and ddI or ddC

Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine, Stavudine, or Didanosine

A Study of Three Anti-HIV Drug Combinations in Patients Who Have Taken Amprenavir

A Comparison of Three Treatments for Advanced HIV Disease in Patients Who Have Received Nucleoside Therapy in the Past

Assessment of Pre-Exposure Prophylaxis (PrEP) Administered at Sexually Transmitted Disease (STD) Clinics

A Study of AZT Plus Ganciclovir in Patients With AIDS and Cytomegalovirus (CMV) Infection